Public Release Summary on the evaluation of the new active zilpaterol hydrochloride in the product Zilmax Medicated Premix

At the request of stakeholders, we have extended the consultation closing date to 23 June 2020.

Your feedback will be submitted to the APVMA anonymously. If you require a response, please contact us.